Pricing database updated August 4, 2026Methodology v1.0How we score →
Compare Providers
Home / Peptides / L-Carnitine
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Written by Dr. Parmis Mojarab, DO·Published July 12, 2026·Last reviewed August 4, 2026·Methodology v1.0
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

L-Carnitine: evidence, legality and safety

Quick answer

L-carnitine is an amino-acid derivative involved in fatty-acid transport, marketed for fat loss and athletic performance. Evidence for meaningful fat-loss or performance benefit in healthy people is weak, and injectable formulations sold by wellness clinics are a different safety consideration from oral supplements.

Regulatory statusAn amino-acid derivative sold as supplement and injectable; performance/fat-loss claims are weak.

What does the evidence actually show?

L-carnitine is an amino-acid derivative involved in fatty-acid transport, marketed for fat loss and athletic performance. Evidence for meaningful fat-loss or performance benefit in healthy people is weak, and injectable formulations sold by wellness clinics are a different safety consideration from oral supplements.

What human clinical evidence exists?

Mixed and generally weak for the marketed fat-loss and performance claims in healthy adults.

What do the animal and laboratory studies show?

Metabolic role is well established; supplementation benefit in replete individuals is not. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

What are the known and potential risks?

GI effects orally; sourcing and sterility for injectables. A trimethylamine-N-oxide (TMAO) cardiovascular signal has been discussed in the literature.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Is it banned in sport?

Injectable use above certain volumes can raise anti-doping method concerns; verify current rules.

Frequently asked questions

Is L-Carnitine FDA-approved?

An amino-acid derivative sold as supplement and injectable; performance/fat-loss claims are weak.

Is there human evidence for L-Carnitine?

Mixed and generally weak for the marketed fat-loss and performance claims in healthy adults.

Is L-Carnitine legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is L-Carnitine banned in sport?

Injectable use above certain volumes can raise anti-doping method concerns; verify current rules.

Sources

  1. U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
  2. World Anti-Doping Agency (WADA) Prohibited List — current edition.
  3. Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.